Polycythemia Vera
Symptoms, Doctors, Treatments, Advances & More

Learn About Polycythemia Vera

What is the definition of Polycythemia Vera?

Polycythemia vera (PV) is a bone marrow disease that leads to an abnormal increase in the number of blood cells. The red blood cells are the most affected blood cell type.

What are the alternative names for Polycythemia Vera?

Primary polycythemia; Polycythemia rubra vera; P. Vera; Myeloproliferative disorder; Erythremia; Splenomegalic polycythemia; Vaquez's disease; Osler's disease; Polycythemia with chronic cyanosis; Erythrocytosis megalosplenica; Cryptogenic polycythemia

What are the causes of Polycythemia Vera?

PV is a disorder of the bone marrow. It mainly causes too many red blood cells to be produced. The numbers of white blood cells and platelets may also be higher than normal.

PV is a rare disorder that occurs more often in men than in women. It is not usually seen in people under age 40. The problem is often linked to a variant gene called JAK2V617F. The cause of this variant gene is unknown. This variant gene is not an inherited disorder.

What are the symptoms of Polycythemia Vera?

In people with PV, there are too many red blood cells in the blood. This results in thicker blood, which can't flow through small blood vessels normally, leading to symptoms such as:

  • Trouble breathing when lying down
  • Dizziness
  • Feeling tired all the time
  • Full feeling in the left upper abdomen (due to enlarged spleen)
  • Headache
  • Itchiness, especially after a warm bath
  • Red skin coloring, especially of the face
  • Shortness of breath
  • Symptoms of blood clots in veins near the skin surface (phlebitis)
  • Vision problems
  • Ringing in the ears (tinnitus)
  • Joint pain
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Polycythemia Vera?

The goal of treatment is to reduce the thickness of the blood and prevent bleeding and clotting problems.

A method called phlebotomy is used to decrease blood thickness. One unit of blood (about 1 pint, or 1/2 liter) is removed each week until the number of red blood cells drops. The treatment is continued as needed.

Medicines that may be used include:

  • Hydroxyurea to reduce the number of red blood cells made by the bone marrow. This medicine may be used when the numbers of other blood cell types are also high.
  • Interferons to lower blood counts, especially in pregnancy.
  • Ruxolitinib (Jakafi) to reduce the number of red blood cells and reduce an enlarged spleen. This medicine is prescribed when hydroxyurea and other treatments have failed.

Taking aspirin to reduce the risk of blood clots may be an option for some people, but aspirin increases the risk for stomach bleeding.

Ultraviolet-B or ultraviolet-A light therapy can reduce the severe itching some people experience.

Who are the top Polycythemia Vera Local Doctors?
Elite in Polycythemia Vera
Hematology | Oncology
Elite in Polycythemia Vera
Hematology | Oncology
Referral required

Atrium Health Levine Cancer Institute

1021 Morehead Medical Drive, 
Charlotte, NC 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Ruben Mesa is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mesa is rated as an Elite provider by MediFind in the treatment of Polycythemia Vera. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Splenectomy. Dr. Mesa is board certified in American Board Of Internal Medicine, Hematology. Dr. Mesa is currently accepting new patients.

Elite in Polycythemia Vera
Elite in Polycythemia Vera
Referral may be required

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
Languages Spoken:
English, Arabic
Accepting New Patients
Offers Telehealth

Abdulraheem Yacoub is a Hematologist practicing medicine in Fairway, Kansas. Dr. Yacoub is rated as an Elite provider by MediFind in the treatment of Polycythemia Vera. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Yacoub is board certified in American Board Of Internal Medicine, Hematology - 2012 and American Board Of Internal Medicine, Medical Oncology - 2011. Dr. Yacoub is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Polycythemia Vera
Elite in Polycythemia Vera
Referral may be required
Minden, NW, DE 

Martin Griesshammer practices practicing medicine in Minden, Germany. Mr. Griesshammer is rated as an Elite expert by MediFind in the treatment of Polycythemia Vera. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Essential Thrombocythemia, Splenomegaly, and Bone Marrow Transplant.

What are the support groups for Polycythemia Vera?

More information and support for people with polycythemia vera and their families can be found at:

  • Blood Cancer United -- bloodcancerunited.org/blood-cancer/myeloproliferative-neoplasms-mpns/polycythemia-vera-pv/sign-and-symptoms
  • MPN Research Foundation -- www.mpnresearchfoundation.org/living-with-an-mpn/
  • National Organization for Rare Disorders -- rarediseases.org/rare-diseases/polycythemia-vera/
  • NIH Genetic and Rare Diseases Information Center -- rarediseases.info.nih.gov/diseases/7422/polycythemia-vera
What is the outlook (prognosis) for Polycythemia Vera?

PV usually develops slowly. Most people do not have symptoms related to the disease at the time of diagnosis. The condition is often diagnosed before severe symptoms occur.

What are the possible complications of Polycythemia Vera?

Complications of PV may include:

  • Acute myelogenous leukemia (AML)
  • Bleeding from the stomach or other parts of the intestinal tract
  • Gout (painful swelling of a joint)
  • Heart failure
  • Myelofibrosis (disorder of the bone marrow in which the marrow is replaced by fibrous scar tissue)
  • Thrombosis (blood clotting, which can cause a stroke, heart attack, or other body damage)
When should I contact a medical professional for Polycythemia Vera?

Contact your provider if symptoms of PV develop.

What are the latest Polycythemia Vera Clinical Trials?
A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of Sapablursen in Polycythemia Vera

Summary: The purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of care (SOC) for Polycythemia Vera (PV) therapy. The study will be conducted in three sequential parts (Part 1a blinded treatment, Part 1b open-label treatment, \& Part 2 long-term extension). Participants may receive treatment for up to 156 weeks.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I Study of Ruxolitinib Plus Abemaciclib for Patients With Primary or Post-polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Summary: The study is being done to see if the combination of ruxolitinib and abemaciclib is a safe and effective treatment for people with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.

Who are the sources who wrote this article ?

Published Date: February 03, 2025
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Gotlib J. Polycythemia vera, essential thrombocythemia, and primary myelofibrosis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 152.

Kremyanskaya M, Najfeld V, Mascarenhas J, Hoffman R. The polycythemias. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 70.

National Cancer Institute website. Myeloproliferative neoplasms treatment (PDQ) -- health professional version. www.cancer.gov/types/myeloproliferative/hp/myeloproliferative-neoplasms-treatment. Updated September 27, 2024. Accessed February 11, 2025.